RT Journal Article
SR Electronic
T1 Simultaneous identification of viruses and SARS-CoV-2 variants with programmable DNA nanobait
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.11.05.21265890
DO 10.1101/2021.11.05.21265890
A1 Filip Bošković
A1 Jinbo Zhu
A1 Ran Tivony
A1 Alexander Ohmann
A1 Kaikai Chen
A1 Mohammed F. Alawami
A1 Milan Đorđević
A1 Niklas Ermann
A1 Joana Pereira Dias
A1 Michael Fairhead
A1 Mark Howarth
A1 Stephen Baker
A1 Ulrich F. Keyser
YR 2021
UL http://medrxiv.org/content/early/2021/11/10/2021.11.05.21265890.abstract
AB Respiratory infections are the major cause of death from infectious disease worldwide. The clinical presentation of many respiratory viruses is indistinguishable; therefore, diagnostic approaches that can identify multiple pathogens are essential for patient management. We aimed to address this challenge with self-assembled DNA nanobait that can simultaneously identify multiple short RNA targets. The nanobait approach relies on specific target selection via toehold-mediated strand displacement and rapid read-out via nanopore sensing. Here, we show this platform can concurrently identify several common respiratory viruses, detecting a panel of short targets of viral nucleic acids from SARS-CoV-2, respiratory syncytial virus (RSV), rhinovirus, influenza, and parainfluenza. Our nanobait could be reprogrammed to discriminate viral variants, and we identified several key SARS-CoV-2 variants with single-nucleotide resolution. We increased assay specificity with bespoke nanobait that could identify numerous short RNA targets in the same viral sample in a complex background of the human transcriptome. Notably, we found that the sequence position in the viral RNA secondary structure is critical for nanobait design. Lastly, we show that nanobait could discriminate between samples extracted from oropharyngeal swabs from negative and positive SARS-CoV-2 patients using programmable target cleavage without pre-amplification. Our system allows for multiplexed identification of native RNA molecules, providing a new scalable approach for diagnostics of multiple respiratory viruses in a single assay.Competing Interest StatementU.F.K. and F.B. have filed a priority patent application for the DNA nanobait method. U.F.K., K.C. and M.A. are co-founders of Cambridge Nucleomics. Other authors do not have competing interests.Funding StatementThe study was funded by multiple funders. All funders are listed in the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was conducted using anonymised samples collected as part of the establishment of a diagnostic screening service in collaboration between the University of Cambridge and Cambridge University Hospitals trust. (https://wellcomeopenresearch.org/articles/5-110/v2). The use of discard samples surplus to that required for clinical testing, and anonymised data review were conducted under the consent waiver granted by Leeds West NHS Research Ethics Committee (ref: 20/YH/0152).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript or supplementary information.